Medasyst Medication Delivery Solution: Why Swallowing Medication Is Failing Millions and the Technology That’s About to Change Everything
For most of us, swallowing a pill is automatic—a simple daily task that barely registers. But for millions worldwide, it’s far from simple. Swallowing medication can be painful, frightening, or even impossible. Medasyst’s medication delivery solution is here to change that.
Introducing one of the most widespread yet overlooked health challenges: difficulty swallowing medication, clinically known as dysphagia. Though rarely discussed publicly, the numbers tell a hidden story of struggle and risk. Medasyst provides a revolutionary solution now available for patients, carers, and healthcare providers.
A Global Problem Hiding Behind Silence
It’s estimated that 1 in 25 people worldwide struggle to swallow medication. While this number is significant, the challenge is even more severe in aged care and chronic health conditions:
- Up to 50% of aged care residents have difficulty swallowing medication
- 64% of stroke survivors struggle with tablets and capsules
- Chronic conditions add millions more:
- Multiple Sclerosis: 2.8 million people
- Traumatic Brain Injury: 69 million new cases annually
- Cerebral Palsy: 18 million people
- Parkinson’s Disease: nearly all face some degree of dysphagia
These patients rely on medication for safety and independence, yet taking it often becomes a daily ordeal. And the most alarming fact? Many never speak up.
A recent study of patients over 65 revealed:
- 68% would not tell their doctor or pharmacist about swallowing difficulties
- 80% would not report if they could not take their medication at all
This silence leads to skipped doses, crushed pills that should never be altered, anxiety, shame, and a growing risk of serious complications such as aspiration pneumonia.

Why the Current Solution Is Failing: The Dangers of Pill Crushing
For decades, healthcare providers have relied on manual pill crushing—by hand, with a mortar and pestle, or using mechanical devices like the Silent Knight. Despite its widespread use in hospitals, aged care, and home care, the approach is fundamentally flawed.
Pill Crushing Is Inconsistent by Design
Results vary widely because crushing depends on the individual performing it:
- Physical strength
- Training
- Experience
- Technique
This variability leads to inconsistent particle sizes and unreliable dose delivery. Independent evaluations have revealed:
- Over 50% of tablets lose a significant amount of active medication when crushed
- In some cases, patients receive 50% or less of the prescribed dose
- Unwettable pills clump instead of dissolving, reducing effectiveness
- Powder residue sticks to crushing devices, meaning even “correctly” crushed doses fall short
For tube-fed patients, inconsistent crushing is the leading cause of PEG tube blockages, resulting in missed doses, emergency nurse callouts, and additional costs.
The Human and Economic Cost Is Enormous
- High rates of musculoskeletal injuries among carers are linked directly to pill crushing tasks
- Incorrect doses and adverse reactions cost the healthcare system thousands in follow-up care
- Compounded liquid medications are expensive and often have short shelf lives
With the global population aged 80+ projected to triple by 2050, this outdated system faces increasing pressure. The question arises: what if there was a better way?
Introducing the Medasyst Mycare Unit: A Breakthrough in Medication Delivery
The Medasyst Mycare Unit offers a revolutionary approach—not just easing swallowing difficulties but transforming how medication is prepared and delivered.
The provisionally patented ultrasonic Mycare Unit converts solid medication into a smooth, consistent liquid suspension. This is more than a device—it’s a healthcare revolution.

How Ultrasonic Disintegration Works and Why It Changes Everything
Unlike crushing, the Mycare Unit uses targeted ultrasonic waves to create a uniform 30–50 ml liquid suspension on demand within minutes, preserving the integrity of the medication.
What the Testing Shows
Independent university testing in Melbourne confirmed:
- Medication efficacy remains intact
- Pharmacokinetics are unchanged:
- The drug reaches the bloodstream as intended
- No chemical alterations
- No loss of therapeutic effect
This ensures medication works correctly every single time.
The New Gold Standard: Up to 99% Dose Delivery
Where manual crushing may deliver half the intended dose, the Mycare Unit consistently achieves:
- 98% or greater dose delivery
- Up to 99% conversion into a clean, uniform liquid suspension
- Less than 2% residue, which disappears with a second rinse
For tube-fed patients, this dramatically reduces the risk of clogging—one of the most dangerous issues in clinical care.
Beyond Safety: A Better Experience for Patients and Carers
1. Ease of Use
Automated, consistent, and effortless. No strength required, no variability between carers.
2. Hygiene and Safety
Disposable proprietary beakers prevent cross-contamination, critical in hospitals and aged care.
3. Masked Flavours for Comfort
Medications often taste unpleasant. Medasyst offers palatable options including:
- Smooth chocolate
- Salted caramel
- Tangy orange
Additional flavours, including diabetic-friendly and vegan formulations, are in development.
4. Cost-Effective and Immediate
Each liquid dose costs around 50 cents. No compounding fees, no waiting periods, no short shelf-life issues. Fresh, reliable, patient-friendly doses are delivered instantly.

Scaling Globally: Leadership, Vision, and the Road Ahead
Medasyst’s mission is clear: “We’re saving lives by enhancing the quality of living and removing the trauma associated with medication consumption.”
Giorgios Mihos, CEO
Leads global investment, regulatory strategy, and manufacturing scale to bring Mycare into hospitals, aged care, home care, and international markets.
Wallace Tench, COO
Ensures seamless integration, training, and operational excellence, delivering immediate and measurable benefits to organisations. This combination of innovation and execution transforms new technology into global healthcare infrastructure.
The Future of Medication Delivery: Medasyst Medication Delivery Solution Has Arrived
Swallowing medication should not be traumatic, dangerous, or reliant on outdated methods. The Medasyst Mycare Unit offers a safer, more humane, and more efficient future where:
- Patients receive up to 99% of their intended dose
- Carers are protected from injury
- Healthcare systems avoid costly medication errors
- Swallowing difficulties no longer cause fear, secrecy, or skipped treatment
- Medication becomes accessible and dignified for everyone
As the global population ages and prescription rates rise by up to 90%, innovation is urgently needed. Medasyst’s medication delivery solution is here to make that shift happen—quickly becoming indispensable in hospitals, aged care facilities, and homes worldwide.
Beyond this, it raises a larger question: what other outdated, high-risk clinical tasks are ready for transformation?
